Efficacy and safety of tangshen formula on patients with type 2 diabetic kidney disease: a multicenter double-blinded randomized placebo-controlled trial.

Efficacy and safety of tangshen formula on patients with type 2 diabetic kidney disease: a multicenter double-blinded randomized placebo-controlled trial.

Persons with diabetes are at high risk of developing diabetic kidney disease (DKD), which is associated with high morbidity and mortality. Current drug therapies for DKD, such as angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), are not entirely satisfactory....

Full description

Bibliographic Details
Main Authors: Ping Li, Yiping Chen, Jianping Liu, Jing Hong, Yueyi Deng, Fang Yang, Xiuping Jin, Jing Gao, Jing Li, Hui Fang, Geling Liu, Liping Shi, Jinhang Du, Yang Li, Meihua Yan, Yumin Wen, Wenying Yang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4418676?pdf=render

Internet

http://europepmc.org/articles/PMC4418676?pdf=render

Similar Items